Stock Report

Download full stock data and analysis for free Last Updated: 03-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Renalytix (RNLX) Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.14

up-down-arrow $0.00 (-3.10%)

As on 06-Dec-2024 09:30EDT

Market cap

info icon

$23 Mln

Revenue (TTM)

info icon

$2 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

18.8

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 9.53 13.13 -28.40 2.75 --
EBIT 9.96 44.38 27.46 8.32 -219.32
Net Profit 8.64 36.29 27.56 -6.93 -232.07
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsJun-24Jun-23Jun-22
EBIT-Margin info -1,431.09-1,642.92-1,261.90-1,240.70-1,790.67
Net Margin info ----------
Return on equity info -281.58-185.32-631.25-148.02-65.49
Return on Capital info -126.40-92.07-213.88-105.47-59.84
Return on Assets info -91.58-69.87-133.59-86.56-54.60
Debt to Equity (x) info -----1.090.660.29

Profitability

View Detailed Peer Comparison

ROCE

-213.88

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
-213.88
-105.47
-59.84
-52.60
-28.57
Peer Median
--
--
--
--
--
ROE

-631.25

--

Profit after tax / Average Net worth * 100

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
-631.25
-148.02
-65.49
-52.99
-28.85
Peer Median
--
--
--
--
--
ROA

-133.59

--

Profit after tax / Average Total assets * 100

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
-133.59
-86.56
-54.60
-48.27
-26.35
Peer Median
--
--
--
--
--
EBIT Margin

-1,261.90

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
-1,261.90
-1,240.70
-1,790.67
-2,278.40
--
Peer Median
--
--
--
--
--
Net Margin

-1,461.60

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
-1,461.60
-1,340.20
-1,524.44
-2,328.97
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

-0.33

--

Year on year growth in net sales

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
-0.33
0.15
0.99
--
--
Peer Median
--
--
--
--
--
EBIT Growth

31.59

--

Year on year growth in operating profit (EBIT)

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
31.59
20.61
-56.55
-206.65
-69.47
Peer Median
--
--
--
--
--
Net Profit Growth

26.64

--

Year on year growth in profit after tax

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
26.64
-0.73
-30.38
-275.41
-66.40
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

-1.09

--

Total debt / Net worth

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
-1.09
0.66
0.29
0.00
0.02
Peer Median
--
--
--
--
--
Short term debt to equity ratio

-0.54

--

(Short term borrowings / Net worth)

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
-0.54
0.25
0.11
0.00
0.01
Peer Median
--
--
--
--
--
Current Ratio

0.53

--

Current Assets / Current Liabilities and Provisions

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
0.53
1.76
3.89
10.46
5.59
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
--
1.71
3.79
10.42
5.49
Peer Median
--
--
--
--
--
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
--
-14,073.67
-26,591.50
-11,323.67
-5,539.00
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

31.54

--

Debtors outstanding / Net Sales * 100

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
31.54
22.80
30.34
80.55
--
Peer Median
--
--
--
--
--
Asset Turnover

0.09

--

Sales / Average Total Assets

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
0.09
0.06
0.04
0.02
--
Peer Median
--
--
--
--
--
Receivable days

119.52

--

Average Debtors / Sales * 365

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
119.52
90.00
129.25
149.31
--
Peer Median
--
--
--
--
--
Inventory Days

122.95

--

Average Inventory / Sales * 365

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
122.95
126.93
134.65
154.23
804.54
Peer Median
--
--
--
--
--
Payable days

474.67

--

Average Creditors / Cost of goods sold * 365

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
474.67
364.64
375.93
1,059.41
9,017.73
Peer Median
--
--
--
--
--
Cash Conversion Cycle

-232.21

--

Receivable Days + Inventory Days - Payable Days

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
-232.21
-147.71
-112.02
-755.87
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

EV/EBITDA

-0.14

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Jun-24
Jun-23
Jun-22
Jun-21
Jun-20
Renalytix (RNLX)
-0.14
0.34
0.60
2.20
--
Peer Median
--
--
--
--
--
loading...
loading...